India’s pharma industry grows 7.8% in April; government says, ‘success of smart schemes’ – Times of India

India’s pharma industry grows 7.8% in April; government says, ‘success of smart schemes’ – Times of India

NEW DELHI: India’s pharmaceutical industry continues its rapid ascent on the global stage, driven by affordability, innovation, and inclusivity. Thesector recorded a 7.8 per cent year-on-year growth in April 2025, according to India Ratings, part of the Fitch Group, as quoted by Press Information Bureau (PIB) on Sunday.This growth reflects continued strong domestic demand and…

Read More
Pharma sector continues to thrive, driven by price-led expansion – Times of India

Pharma sector continues to thrive, driven by price-led expansion – Times of India

Representative image (Picture credit: IANS) The Indian pharmaceutical market continued rising in April 2025, achieving a strong annual growth of 7.8%, with total sales reaching a remarkable Rs 19,711 crore.According to a report by Pharmatrack, the sector recorded an impressive Rs 1,424 crore in additional sales this month, highlighting its continued resilience and strong demand.The…

Read More
Donald Trump tariff relief for now: India’s pharma sector navigates an uncertain US trade future – Times of India

Donald Trump tariff relief for now: India’s pharma sector navigates an uncertain US trade future – Times of India

Trump has indicated that there may be potential imposition of reciprocal tariffs on pharmaceuticals as well. (AI image) By Hitesh SharmaThe ongoing trade dynamics between India and the United States may have implications for the pharmaceutical sector, particularly in light of recent tariff announcements. As the US government implements reciprocal tariffs on imports from over…

Read More
‘Did not attack Indian pharma warehouse’: Russian embassy blames Ukraine | India News – The Times of India

‘Did not attack Indian pharma warehouse’: Russian embassy blames Ukraine | India News – The Times of India

The Russian embassy in India on Thursday dismissed the claims made by Ukraine that it attacked Indian pharmaceutical company Kusum calling the news fake. It, in turn, accused the war-torn nation of attacking the warehouse saying “one of Ukrainian air defence missiles fell on Kusum Healthcare’s warehouse setting it on fire.”“In response to the accusations…

Read More
Russia denies attacking Indian pharma godown in Kyiv, blames Ukrainian missiles

Russia denies attacking Indian pharma godown in Kyiv, blames Ukrainian missiles

The Russian Embassy in India has denied accusations made by Ukraine that a Russian missile struck the warehouse of Indian pharmaceutical company Kusum Healthcare in Kyiv. Responding to the Ukrainian Embassy’s allegations, the Russian side said that the Russian Armed Forces “did not attack or plan to attack on April 12, 2025, Kusum Healthcare’s pharmacy…

Read More
Tariff Trade War के बीच ये 4 Indian Pharma Stocks देंगे अच्छा Return | Paisa Live

Tariff Trade War के बीच ये 4 Indian Pharma Stocks देंगे अच्छा Return | Paisa Live

अगर आपके Portfolio में Pharma Stocks हैं तो ये खबर आके लिए बेहद जरूरी हैं क्योंकि आगे जाकर हो सकता हैं कई बड़ी घोषणाएं हो। US President Donald Trump का tariff का सिलसिला थमने का नाम नहीं ले रहा हैं। trump ने India पर 26% tariff rate लगाया लेकिन pharma sector को untouched रखा था…

Read More
US tariff: ‘No major impact on pharma’ – The Times of India

US tariff: ‘No major impact on pharma’ – The Times of India

The domestic pharma industry in India may not face significant impact from potential US tariffs on pharmaceutical exports. Indian generics, which dominate exports and are in continuous demand, could absorb additional costs. Key industry players are awaiting further details on the tariffs while engaging in bilateral talks. NEW DELHI: The domestic pharma industry may not…

Read More
Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti – Times of India

Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti – Times of India

HYDERABAD: Aurobindo Pharma’s wholly-owned subsidiary, CuraTeQ Biologics Private Limited, received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European drug regulatory body, the European Medicines Agency (EMA), for its filgrastim biosimilar, Zefylti. The committee recommended granting marketing authorisation.The Hyderabad-based company stated that Zefylti is its first biosimilar to…

Read More